Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-18

Clinical Trial Update: The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether oral vitamin D supplementation reduces peritoneal dialysis-related peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D supplementation (Cholecalciferol)

Snippet

Sponsor: Peking University First Hospital | Conditions: Peritoneal Dialysis-associated Peritonitis, Vitamin D Deficiency | Phase 2 | Status: COMPLETED